3
Clinical Trials associated with Follicle stimulating hormone biosimilar(Bharat Serums & Vaccines Ltd.) / Active, not recruitingPhase 3 A Randomized, Parallel-group, Multi-Center, Assessor-blind Phase 3 Study to Compare the Efficacy, Safety and Ease of Use of Two Follicle Stimulating Hormone -Human Recombinant (r-hFSH) 900 IU (66.0 µg) / 1.5mL Solution for Injection in Prefilled Pen (Foligraf®- Manufactured by BSV and Gonal-f® Manufactured by Merck Serono) in Subjects Undergoing Controlled Ovarian Stimulation for Assisted Reproductive Technology - REFRESH
A Prospective, Multicenter, open, Phase IV Clinical Trial to test efficacy and safety of Highly Purified Follicle-Stimulating Hormone in subjects Undergoing assisted reproductive Technique (ART)
A prospective, multicenter, randomized, open, comparative clinical trial to test efficacy and safety of 2 brands of highly purified follicle-stimulating hormone in subjects undergoing their first cycle of invitro fertilization with intracytoplasmic sperm injection (ICSI).
100 Clinical Results associated with Follicle stimulating hormone biosimilar(Bharat Serums & Vaccines Ltd.)
100 Translational Medicine associated with Follicle stimulating hormone biosimilar(Bharat Serums & Vaccines Ltd.)
100 Patents (Medical) associated with Follicle stimulating hormone biosimilar(Bharat Serums & Vaccines Ltd.)
100 Deals associated with Follicle stimulating hormone biosimilar(Bharat Serums & Vaccines Ltd.)